Skip to main content
. 2021 Oct 13;12:724277. doi: 10.3389/fimmu.2021.724277

Figure 4.

Figure 4

Connections between biological AD risk genes and drugs are potentially useful for AD. Representative connections between AD biological genes (green); genes in PPIs (yellow); target drug for drugs under clinical trial (blue); the drug was supported by case series (pink), and drugs with preclinical data for AD (grey); indication (orange). Grey lines indicate connections. All other biological gene-drug connections are through the PPI network.